Men's Health Center, Department of Family Medicine and Urology, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
J Sex Med. 2012 Mar;9(3):641-51; quiz 652. doi: 10.1111/j.1743-6109.2012.02649.x.
Female sexual function is dependent, in part, upon normal endothelial function within the genital arterial (hypogastric-cavernosal) vascular bed. The first two Princeton Consensus Conferences were focused on relationships between male sexual function and cardiovascular health, and development of contemporary clinical guidelines for dysfunction management.
The third Princeton Consensus Conference updated recommendations and assessed, for the first time, the association between female sexual dysfunction (FSD) and presence of systemic vascular endothelial dysfunction and its consequences in women. This report focuses on the association between cardiometabolic risk factors and female sexual health.
A panel of experts reviewed multinational data concerning associations between several cardiometabolic risks in women (hypertension, dyslipidemia and/or hyperlipemia, cigarette smoking, diabetes mellitus, and metabolic syndrome/obesity) and sexual health. Literature was reviewed concerning associations between FSD and presence or absence of cardiovascular disease, predictive association of FSD with cardiovascular events, and the possibility of vascular risk factor treatment modifying FSD.
Main outcome measures used were cardiometabolic risk factors and female sexual health, specifically genital arousal.
Women treated for hypertension have more FSD than normotensives. Women with hyperlipidemia but without cardiovascular disease have more FSD than women without hyperlipidemia. Women with metabolic syndrome/obesity have more FSD than those without. Cardiometabolic risk factors, diabetes, and coronary heart disease are associated with more FSD. Data support that treatment of metabolic syndrome/obesity is associated with less FSD. Currently, there are no data to support that FSD is a predictor of future cardiovascular events.
Female sexual health is complex: there is relative independence between subjective and objective aspects of arousal and desire, with numerous contributing factors (hormonal, psychological, interpersonal, and social). Based on limited current data, there appears to be an association between female sexual health and vascular risk factors (hypertension, hyperlipidemia, metabolic syndrome/obesity, diabetes, and coronary heart disease). More research is needed.
女性性功能部分依赖于生殖道(阴部-海绵体)血管床的正常内皮功能。前两次普林斯顿共识会议的重点是男性性功能与心血管健康之间的关系,以及制定当代性功能障碍管理临床指南。
第三次普林斯顿共识会议更新了建议,并首次评估了女性性功能障碍(FSD)与系统性血管内皮功能障碍及其对女性影响之间的关系。本报告重点关注心血管代谢危险因素与女性性健康之间的关系。
专家组审查了涉及女性几种心血管代谢危险因素(高血压、血脂异常和/或高脂血症、吸烟、糖尿病和代谢综合征/肥胖症)与性健康之间关联的多国数据。还审查了有关 FSD 与心血管疾病的存在或不存在、FSD 与心血管事件的预测关联以及血管危险因素治疗是否可能改变 FSD 的文献。
主要观察指标为心血管代谢危险因素和女性性健康,特别是生殖器唤起。
接受高血压治疗的女性比血压正常的女性有更多的性功能障碍。患有血脂异常但无心血管疾病的女性比没有血脂异常的女性有更多的性功能障碍。患有代谢综合征/肥胖症的女性比没有该病症的女性有更多的性功能障碍。心血管代谢危险因素、糖尿病和冠心病与更多的性功能障碍有关。数据支持代谢综合征/肥胖症的治疗与较少的性功能障碍有关。目前,尚无数据支持性功能障碍是未来心血管事件的预测因素。
女性性健康是复杂的:唤起和欲望的主观和客观方面相对独立,有许多因素(激素、心理、人际和社会)会产生影响。根据目前有限的数据,女性性健康与血管危险因素(高血压、血脂异常、代谢综合征/肥胖症、糖尿病和冠心病)之间似乎存在关联。需要进一步研究。